Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The future of clinical cancer genomics.

Offit K.

Semin Oncol. 2016 Oct;43(5):615-622. doi: 10.1053/j.seminoncol.2016.10.002. Epub 2016 Oct 18.

2.

The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011-2014.

Trivers KF, Rodriguez JL, Cox SL, Crane BE, Duquette D.

Healthcare (Basel). 2015 Oct 15;3(4):948-63. doi: 10.3390/healthcare3040948.

3.

Public Health Approaches and Barriers to Educating Providers about Hereditary Breast and Ovarian Cancer Syndrome.

Trepanier AM, Supplee L, Blakely L, McLosky J, Duquette D.

Healthcare (Basel). 2016 Mar 11;4(1). pii: E19. doi: 10.3390/healthcare4010019.

4.

Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review.

Buchanan AH, Rahm AK, Williams JL.

Front Oncol. 2016 May 13;6:120. doi: 10.3389/fonc.2016.00120. eCollection 2016. Review.

5.

Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study.

Bradbury A, Patrick-Miller L, Harris D, Stevens E, Egleston B, Smith K, Mueller R, Brandt A, Stopfer J, Rauch S, Forman A, Kim R, Fetzer D, Fleisher L, Daly M, Domchek S.

J Med Internet Res. 2016 Feb 1;18(2):e23. doi: 10.2196/jmir.4564.

6.

Family history intake: a challenge to personalized approaches in health promotion and disease prevention.

Endevelt R, Goren I, Sela T, Shalev V.

Isr J Health Policy Res. 2015 Nov 20;4:60. doi: 10.1186/s13584-015-0055-2. eCollection 2015.

7.

Effects of age on the detection and management of breast cancer.

McGuire A, Brown JA, Malone C, McLaughlin R, Kerin MJ.

Cancers (Basel). 2015 May 22;7(2):908-29. doi: 10.3390/cancers7020815. Review.

8.

Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.

Buchanan AH, Datta SK, Skinner CS, Hollowell GP, Beresford HF, Freeland T, Rogers B, Boling J, Marcom PK, Adams MB.

J Genet Couns. 2015 Dec;24(6):961-70. doi: 10.1007/s10897-015-9836-6. Epub 2015 Apr 3.

9.

Epigenetic changes in BRCA1-mutated familial breast cancer.

Downs B, Wang SM.

Cancer Genet. 2015 May;208(5):237-40. doi: 10.1016/j.cancergen.2015.02.001. Epub 2015 Feb 13. Review.

10.

Breast cancer genetic testing awareness, attitudes and intentions of Latinas living along the US-Mexico border: a qualitative study.

Chalela P, Pagán JA, Su D, Muñoz E, Ramirez AG.

J Community Med Health Educ. 2012;2. pii: 1000152.

11.

Development of a communication protocol for telephone disclosure of genetic test results for cancer predisposition.

Patrick-Miller LJ, Egleston BL, Fetzer D, Forman A, Bealin L, Rybak C, Peterson C, Corbman M, Albarracin J, Stevens E, Daly MB, Bradbury AR.

JMIR Res Protoc. 2014 Oct 29;3(4):e49. doi: 10.2196/resprot.3337.

12.

Understanding the implications of the breast cancer pathology report: a case study.

Beikman S, Gordon P, Ferrari S, Siegel M, Zalewski MA, Rosenzweig MQ.

J Adv Pract Oncol. 2013 May;4(3):176-81. Review.

13.

Role of BRCA1 and BRCA2 gene mutations in epithelial ovarian cancer in Indian population: a pilot study.

Sharma S, Rajaram S, Sharma T, Goel N, Agarwal S, Banerjee BD.

Int J Biochem Mol Biol. 2014 May 15;5(1):1-10. eCollection 2014.

14.

Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system.

Bellcross CA, Peipins LA, McCarty FA, Rodriguez JL, Hawkins NA, Hensley Alford S, Leadbetter S.

Genet Med. 2015 Jan;17(1):43-50. doi: 10.1038/gim.2014.68. Epub 2014 Jun 19.

15.

The translational potential of research on the ethical, legal, and social implications of genomics.

Burke W, Appelbaum P, Dame L, Marshall P, Press N, Pyeritz R, Sharp R, Juengst E.

Genet Med. 2015 Jan;17(1):12-20. doi: 10.1038/gim.2014.74. Epub 2014 Jun 19. Review.

16.

Genome instability in blood cells of a BRCA1+ breast cancer family.

Xiao F, Kim YC, Snyder C, Wen H, Chen PX, Luo J, Becirovic D, Downs B, Cowan KH, Lynch H, Wang SM.

BMC Cancer. 2014 May 19;14:342. doi: 10.1186/1471-2407-14-342.

17.

Preventive care and evaluation of the adolescent with a breast mass.

Jayasinghe Y.

Semin Plast Surg. 2013 Feb;27(1):13-8. doi: 10.1055/s-0033-1343990.

18.

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.

Sharma P, Klemp JR, Kimler BF, Mahnken JD, Geier LJ, Khan QJ, Elia M, Connor CS, McGinness MK, Mammen JM, Wagner JL, Ward C, Ranallo L, Knight CJ, Stecklein SR, Jensen RA, Fabian CJ, Godwin AK.

Breast Cancer Res Treat. 2014 Jun;145(3):707-14. doi: 10.1007/s10549-014-2980-0. Epub 2014 May 7.

19.

A randomized, controlled trial to increase discussion of breast cancer in primary care.

Kaplan CP, Livaudais-Toman J, Tice JA, Kerlikowske K, Gregorich SE, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Karliner LS.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1245-53. doi: 10.1158/1055-9965.EPI-13-1380. Epub 2014 Apr 24.

20.

Challenges in meeting Healthy People 2020 objectives for cancer-related preventive services, National Health Interview Survey, 2008 and 2010.

Brown ML, Klabunde CN, Cronin KA, White MC, Richardson LC, McNeel TS.

Prev Chronic Dis. 2014 Feb 27;11:E29. doi: 10.5888/pcd11.130174.

Supplemental Content

Support Center